Business Continuity and Infection Prevention Measures in Response to COVID-19
First written in FY2020. 2 of 6 entries say "Advanced", first in FY2021-Q2. Latest entry: FY2022.
The whole theme swung hardest in 2026: 1 of 12 companies on the "Worse" side.
3 other companies' latest entry also says "Reframed".
- FY2022ReframedAnnual report
「The “Special New Coronavirus Response Headquarters” was dissolved at the end of March 2022. The Company transitioned to a “living with COVID-19” management structure under which necessary measures against COVID-19 would be implemented as part of normal business activities.」
The response to COVID-19 changed from emergency measures led by the special response headquarters to a “living with COVID-19” management structure integrated into normal business activities. Meanwhile, plant shutdowns due to supply constraints continued. - FY2022-Q3Plant shutdowns continued due to supply constraints and the spread of infectionsAnnual report
「Due to supply disruptions involving semiconductors supplied by suppliers against the backdrop of global semiconductor supply issues, and component supply disruptions caused by the spread of COVID-19 infections among suppliers, operations at Gunma Plant, comprising the Main Plant, Yajima Plant and Oizumi Plant, were suspended on 28 January, from 31 January to 2 February, and from 7 to 8 February 2022.」
As the Company continued responding to disruptions in parts supplies as part of its pandemic business continuity measures, multiple suspensions of operations at the Gunma Plant occurred during the following fiscal year. - FY2022-Q2Production adjustments and plant shutdowns continued amid supply constraintsAnnual report
「During the three months ended 30 September, parts procured from business partners were subject to supply constraints due to the global semiconductor shortage and the spread of COVID-19 infections in Southeast Asia. As a result, production was adjusted at facilities in the United States and Japan, and domestic operations were temporarily suspended in September.」
For business continuity measures in response to the pandemic, parts supply constraints caused by the semiconductor shortage and the spread of infections in Southeast Asia led to production adjustments in the United States and Japan, with domestic operations temporarily suspended in September. - FY2021AdvancedAnnual report
「While the decline in automotive demand caused by COVID-19 gradually recovered from the second quarter onward, particularly in our core overseas markets, we faced a global semiconductor shortage affecting the automotive industry and other sectors. We also experienced supply disruptions affecting some parts procured from business partners, resulting in production adjustments, including a 2-day suspension at some plants in January 2021 and a suspension of operations from 10 April 2021 onward.」
As part of its pandemic response, the Company advanced remote work, strengthened IT infrastructure, held online events and established new-normal workplace arrangements. At the same time, semiconductor shortages led to plant shutdowns and production adjustments, while the Company sought to maintain supplies through model changes and other measures. - FY2021-Q2AdvancedAnnual report
「During the six months ended 30 September, automotive segment production was temporarily suspended at overseas facilities from late March and at domestic facilities from early April due to the spread of COVID-19, with production resuming at both in early May. However, because the impact on the supply chain and sales activities continued, production volumes were adjusted overseas through the end of May and domestically through late June. From July onward, production was at approximately the same level as in the year-earlier period, partly because sales in North America recovered faster than expected.」
For business continuity measures in response to the pandemic, the Company disclosed the resumption of production at overseas and domestic facilities, production volume adjustments, and the recovery to year-earlier levels from July onward. - FY2020First statedAnnual report
「In early February 2020, we established a “New Pneumonia Response Headquarters” led by the CEO (Chief Executive Officer). In practice, under the overall direction of the CRMO (Chief Risk Management Officer), we gathered information from group companies in Japan and overseas and took measures to prevent the spread of infection and continue business activities in response to changing circumstances, prioritizing the health and safety of customers, business partners and employees.」
Response measures for COVID-19 were disclosed as a new initiative theme, including centralized information management by the response headquarters, restrictions on business travel and events, staggered working hours and remote work, production stoppages and resumptions, support for medical facilities, and securing financing capacity.